Shares of Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) have been assigned an average rating of “Moderate Buy” from the fifteen brokerages that are covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month […]

Shares of Nasdaq, Inc. (NASDAQ:NDAQ – Get Free Report) have received an average recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the stock, MarketBeat.com reports. Five analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average twelve-month target price among […]

Asana, Inc. (NYSE:ASAN – Get Free Report) has earned an average rating of “Hold” from the fourteen analysts that are covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month […]

The AES Co. (NYSE:AES – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has given a strong buy recommendation to the […]

Shares of Renasant Co. (NASDAQ:RNST – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The […]

Shares of Chewy, Inc. (NYSE:CHWY – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-one research firms that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and twelve have assigned a buy recommendation […]

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-four analysts that are covering the company, Marketbeat reports. Seven research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. The average 12 month target price among […]

Insmed Incorporated (NASDAQ:INSM – Get Free Report) has been given an average rating of “Buy” by the sixteen brokerages that are presently covering the company, MarketBeat reports. Sixteen research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have issued a report on the stock in the […]

Axos Financial, Inc. (NYSE:AX – Get Free Report) has earned an average rating of “Moderate Buy” from the four analysts that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month target price […]

Boston Scientific (NYSE:BSX – Free Report) had its price objective boosted by Evercore ISI from $82.00 to $90.00 in a research note released on Tuesday, Benzinga reports. Evercore ISI currently has an outperform rating on the medical equipment provider’s stock. Several other equities research analysts have also recently weighed in on BSX. Raymond James increased […]

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) has earned a consensus rating of “Hold” from the five ratings firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the […]

StockNews.com upgraded shares of Infosys (NYSE:INFY – Free Report) from a hold rating to a buy rating in a research report report published on Monday. INFY has been the subject of a number of other reports. Macquarie raised Infosys from an underperform rating to a neutral rating in a research note on Friday, July 19th. […]

Boston Scientific (NYSE:BSX – Free Report) had its price objective boosted by Evercore ISI from $82.00 to $90.00 in a research note released on Tuesday, Benzinga reports. Evercore ISI currently has an outperform rating on the medical equipment provider’s stock. Several other equities research analysts have also recently weighed in on BSX. Raymond James increased […]

Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has earned an average rating of “Moderate Buy” from the ten research firms that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month […]

Par Pacific (NYSE:PARR – Get Free Report) was upgraded by equities researchers at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued on Wednesday, Marketbeat Ratings reports. The firm presently has a $30.00 price objective on the stock, down from their previous price objective of $36.00. JPMorgan […]

Carrier Global (NYSE:CARR – Get Free Report) had its price objective lifted by stock analysts at Oppenheimer from $74.00 to $88.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s price objective suggests a potential upside of 9.95% from the stock’s current price. A […]

Hilltop (NYSE:HTH – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday. Several other research firms also recently commented on HTH. Keefe, Bruyette & Woods increased their price objective on shares of Hilltop from $33.00 to $35.00 […]

Agilent Technologies (NYSE:A – Free Report) had its price objective raised by Evercore ISI from $135.00 to $145.00 in a report issued on Tuesday morning, Marketbeat Ratings reports. The firm currently has an in-line rating on the medical research company’s stock. A has been the topic of several other research reports. Wells Fargo & Company […]

Shares of BRP Inc. (NASDAQ:DOOO – Get Free Report) have been given an average recommendation of “Hold” by the nine brokerages that are presently covering the company, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating […]

Emera Incorporated (TSE:EMA – Get Free Report) has been given an average rating of “Hold” by the ten analysts that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and five have issued a buy recommendation on the company. The […]

IGM Biosciences (NASDAQ:IGMS – Get Free Report) was downgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating in a research note issued to investors on Tuesday, Marketbeat.com reports. They currently have a $9.00 target price on the stock, down from their previous target price of $12.00. JPMorgan Chase […]